PREVENTION OF GRAFT-VERSUS-HOST DISEASE WITH T-CELLS INCLUDING POLYNUCLEOTIDES ENCODING NEGATIVE SELECTIVE MARKERS - Patent 0977595

(19)

(11)

EP 0 977 595 A1

(12)

(43)	Date of publication:
	09.02.2000 Bulletin 2000/06

(21)	Application number: 97925747.4

(22)	Date of filing: 28.05.1997

(51)	International Patent Classification (IPC)⁷: A61K 48/00, C12N 15/09, C12N 15/85

(86)	International application number:
	PCT/US9709/040

(87)	International publication number:
	WO 9745/142 (04.12.1997 Gazette 1997/52)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	RO SI

(30)

Priority:

31.05.1996 US 656451

(71)	Applicant: GENETIC THERAPY, INC.
	Gaithersburg, MD 20878 (US)

(72)	Inventors:
	MUNSHI, Nikhil Little Rock, AR 72212 (US) ENNIST, David, L. Bethesda, MD 20817 (US) JACOB, William, F. Germantown, MD 20874 (US) CHIANG, Yawen, L. Potomac, MD 20854 (US)

(74)	Representative: Becker, Konrad et al
	Novartis AGGeistiges Eigentum KonzernPatent- und Markenabteilung CHPostfach 4002 Basel 4002 Basel (CH)

(54)	PREVENTION OF GRAFT-VERSUS-HOST DISEASE WITH T-CELLS INCLUDING POLYNUCLEOTIDES ENCODING NEGATIVE SELECTIVE MARKERS